© 2018 HealthDay. All rights reserved.
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
TUESDAY, Nov. 27, 2018 -- A major update of the United States' system for approving medical devices was announced yesterday by the Food and Drug Administration.
TUESDAY, Nov. 27, 2018 -- Patient and family partnership in care should include treatment of patients and families with dignity and respect, their active engagement in all aspects of care, and their contribution to the improvement of health care systems and education of health care professionals, according to a position paper published online Nov. 27 in the Annals of Internal Medicine.
MONDAY, Nov. 26, 2018 -- Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets, according to a report published by the Robert Wood Johnson Foundation and the Urban Institute.
Report: How Have Workers Fared Under the ACA?
TUESDAY, Nov. 20, 2018 -- The U.S. Preventive Services Task Force (USPSTF) recommends HIV screening for individuals aged 15 to 65 years, including all pregnant women, and pre-exposure prophylaxis (PrEP) should be offered to those at high risk of HIV. These findings form the basis of two draft recommendation statements published online Nov. 20 by the USPSTF.
MONDAY, Nov. 19, 2018 -- The risk for sexual transmission of HIV is negligible when an HIV-positive sex partner adheres to antiretroviral therapy and maintains viral suppression, according to research published in the November issue of CMAJ, the journal of the Canadian Medical Association.
FRIDAY, Nov. 16, 2018 -- In the first six months of 2018, 8.8 percent of U.S. individuals of all ages were uninsured, which was not significantly different from 2017, according to a report published Nov. 15 by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
THURSDAY, Nov. 15, 2018 -- Rising drug spending in the United States is being fueled by expensive name-brand prescription medicines, a new study shows.
THURSDAY, Nov. 15, 2018 -- Data from patient- and family-reported error narratives indicate that problems related to patient-physician interactions are major contributors to diagnostic errors, according to a study published in the November issue of Health Affairs.
Abstract/Full Text (subscription or payment may be required)
WEDNESDAY, Nov. 14, 2018 -- By collecting data on suicides by medical students, residents, and fellows, the American Medical Association hopes to identify ways to reduce suicides among doctors-in-training. The data collection policy was approved at a meeting yesterday.
WEDNESDAY, Nov. 14, 2018 -- Investigations of hepatitis A outbreaks in four states in 2017 suggested a shift toward increasing person-to-person transmission of hepatitis A, according to research published in the Nov. 2 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
WEDNESDAY, Nov. 7, 2018 -- Hundreds of thousands more low-income Americans could get health insurance after voters in three Republican-leaning states approved Medicaid expansion in the midterm elections.
TUESDAY, Nov. 6, 2018 -- Stratifying tuberculosis (TB) patients by disease severity may enable shorter treatment regimens, according to a study published online Nov. 5 in Nature Medicine.
Abstract/Full Text (subscription or payment may be required)
MONDAY, Nov. 5, 2018 -- A majority of internists still report financial ties to industry, according to a study published online Oct. 5 in the Journal of General Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
FRIDAY, Nov. 2, 2018 -- The federal government website where Americans can sign up for health insurance under the Affordable Care Act is up and running, officials said yesterday.
THURSDAY, Nov. 1, 2018 -- There is a high prevalence of financial conflicts of interest among authors of clinical practice guidelines (CPGs) related to high-revenue medications and in gastroenterology, according to two research letters published online Oct. 29 in JAMA Internal Medicine.
Posted: December 2018